SILK 0.00 Stock Price Silk Road Medical, Inc
Range: | 6.08-27.51 | Vol Avg: | 2061398 | Last Div: | 0 | Changes: | -0.01 |
Beta: | 1.54 | Cap: | 1.12B | Currency: | USD | Exchange: | NASDAQ |
Sector: | Healthcare | IPO: | Thu Apr 04 2019 | Empoloyees: | 474 |
CUSIP: | 82710M100 | CIK: | 0001397702 | ISIN: | US82710M1009 | Country: | US |
CEO: | Mr. Charles S. McKhann | Website: | https://silkroadmed.com |
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.